These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 3317056

  • 1. Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.
    Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, Emanuel D, Laver J, O'Reilly RJ.
    N Engl J Med; 1987 Dec 24; 317(26):1618-24. PubMed ID: 3317056
    [Abstract] [Full Text] [Related]

  • 2. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C, Girgis M, Blum W, Brown R, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Lin HS, Dipersio J, Adkins D.
    Biol Blood Marrow Transplant; 2004 May 24; 10(5):310-9. PubMed ID: 15111930
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S.
    Bone Marrow Transplant; 1996 Oct 24; 18(4):741-6. PubMed ID: 8899189
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 24; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 5. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B, Weisdorf DJ, Kim T, Kersey JH, Ramsay NK.
    Bone Marrow Transplant; 1990 Feb 24; 5(2):83-9. PubMed ID: 2107007
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).
    Dini G, Boni L, Abla O, Uderzo C, Polchi P, Locatelli F, Di Bartolomeo P, Arcese W, Iori AP, Rossetti F.
    Bone Marrow Transplant; 1994 Jun 24; 13(6):771-6. PubMed ID: 7920313
    [Abstract] [Full Text] [Related]

  • 7. The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.
    Cook G, Clark RE, Crawley C, Mackinnon S, Russell N, Thomson K, Pearce RM, Towlson K, Marks DI.
    Biol Blood Marrow Transplant; 2006 Mar 24; 12(3):293-300. PubMed ID: 16503498
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation.
    De Witte T, Schattenberg A, Preijers F, Raymakers R, Muus P, Wessels J.
    Bone Marrow Transplant; 1993 Mar 24; 12 Suppl 3():S2-6. PubMed ID: 8124252
    [Abstract] [Full Text] [Related]

  • 9. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL.
    Bone Marrow Transplant; 1994 Nov 24; 14(5):751-7. PubMed ID: 7889008
    [Abstract] [Full Text] [Related]

  • 10. [Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
    Schmitz N, Kayser W, Gassmann W, Euler HH, Wüstemann M, Brix F, Dühmke E, Hebbinghaus D, Gremmel H, Schaub J.
    Dtsch Med Wochenschr; 1985 Sep 27; 110(39):1488-93. PubMed ID: 3896727
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C, Aversa F, Raymondi C, Marsella AR, Panizza BM, Perrucci E, Piro F, Maranzano E, Lupattelli M, Martelli MF, Latini P.
    Cancer J Sci Am; 1996 Sep 27; 2(6):330-4. PubMed ID: 9166553
    [Abstract] [Full Text] [Related]

  • 12. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
    Hirabayashi N, Goto S, Ishii M, Yuge M, Mitsuma A, Noda N.
    Bone Marrow Transplant; 1998 Jun 27; 21(11):1079-83. PubMed ID: 9645568
    [Abstract] [Full Text] [Related]

  • 13. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H.
    N Engl J Med; 1983 Dec 01; 309(22):1347-53. PubMed ID: 6355849
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate.
    Fyles GM, Messner HA, Lockwood G, Curtis JE, Rider W, Minden MD, Meharchand JM, Lipton J, Tritchler D, Van Dyk J.
    Bone Marrow Transplant; 1991 Dec 01; 8(6):453-63. PubMed ID: 1790425
    [Abstract] [Full Text] [Related]

  • 15. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
    Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR.
    Biol Blood Marrow Transplant; 2006 Jul 01; 12(7):749-57. PubMed ID: 16785064
    [Abstract] [Full Text] [Related]

  • 16. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG, McGlave PB, Kim T, Vallera DA, Goldman AI, Bostrom B.
    N Engl J Med; 1987 Aug 20; 317(8):461-7. PubMed ID: 3302708
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
    Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, Fehse N, Waschke O, Fehse B, Kabisch H, Zander AR.
    Bone Marrow Transplant; 2006 Jan 20; 37(1):45-50. PubMed ID: 16258531
    [Abstract] [Full Text] [Related]

  • 18. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.
    Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL.
    N Engl J Med; 1980 May 08; 302(19):1041-6. PubMed ID: 6245359
    [Abstract] [Full Text] [Related]

  • 19. [Allogeneic bone marrow transplantation in acute lymphoblastic leukemia of children. Analysis of prognostic factors. GEGMO (Bone Marrow Study Group) study].
    Bordigoni P, Vernant JP, Souillet G, Philippe N, Maraninchi D.
    Arch Fr Pediatr; 1986 Dec 08; 43(10):765-8. PubMed ID: 3548632
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun 08; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.